|
| 38091020 | Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. | JAMA Surg | 2024 |
| 37863697 | Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer. | Surgery | 2024 |
| 37906382 | Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer. | Ann Surg Oncol | 2024 |
| 37878154 | Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer. | Breast Cancer Res Treat | 2024 |
| 37929785 | Repeat sentinel lymph node surgery for locally recurrent breast cancer after prior mastectomy. | J Surg Oncol | 2024 |
| 37872454 | Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients. | Ann Surg Oncol | 2024 |
| 36380012 | Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. | Breast Cancer Res Treat | 2023 |
| 37516725 | ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer. | Ann Surg Oncol | 2023 |
| 37615191 | Lessons learned from the COVID-19 pandemic: Using telemedicine for pre-operative surgical evaluation in breast disease. | J Telemed Telecare | 2023 |
| 37460743 | Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer. | Ann Surg Oncol | 2023 |
| 37223927 | Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast. | Clin Cancer Res | 2023 |
| 33160859 | MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. | Acad Radiol | 2022 |
| 35773563 | Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy. | Ann Surg Oncol | 2022 |
| 35653124 | Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031). | Clin Cancer Res | 2022 |
| 35503494 | Serum hormone levels and normal breast histology among premenopausal women. | Breast Cancer Res Treat | 2022 |
| 35834142 | Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer. | Ann Surg Oncol | 2022 |
| 35366464 | The breast tissue microbiome, stroma, immune cells and breast cancer. | Neoplasia | 2022 |
| 35830290 | Chest wall resection for breast cancer: 21st century Mayo clinic experience. | J Surg Oncol | 2022 |
| 35789303 | Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation. | Ann Surg Oncol | 2022 |
| 35854027 | Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. | Ann Surg Oncol | 2022 |
| 35821041 | Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence. | Breast Cancer Res | 2022 |
| 35569077 | Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67. | Ann Surg Oncol | 2022 |
| 35451727 | Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database. | Ann Surg Oncol | 2022 |
| 35385996 | Sexual Well-Being After Nipple-Sparing Mastectomy: Does Preservation of the Nipple Matter? | Ann Surg Oncol | 2022 |
| 35776260 | ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer-Effects of Age and Tumor Ki67. | Ann Surg Oncol | 2022 |
| 35849283 | Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma. | Ann Surg Oncol | 2022 |
| 36109410 | ASO Visual Abstract: Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. | Ann Surg Oncol | 2022 |
| 35871670 | ASO Visual Abstract: Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk. | Ann Surg Oncol | 2022 |
| 35870053 | ASO Visual Abstract: Lack of Clinical Value for Immunohistochemistry for Sentinel Lymph Node Assessment in Invasive Lobular Carcinoma. | Ann Surg Oncol | 2022 |
| 36114500 | Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics. | BMC Med Genomics | 2022 |
| 35876930 | ASO Visual Abstract: Overuse of Axillary Surgery for Patients With Ductal Carcinoma In Situ: Opportunity for De-Escalation. | Ann Surg Oncol | 2022 |
| 35876925 | Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk. | Ann Surg Oncol | 2022 |
| 35876921 | ASO Visual Abstract: Factors Influencing Non-Sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer. | Ann Surg Oncol | 2022 |
| 35046392 | Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning. | NPJ Breast Cancer | 2022 |
| 35177654 | Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer. | NPJ Breast Cancer | 2022 |
| 34902335 | Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients. | Lancet Oncol | 2022 |
| 34812981 | Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management. | Ann Surg Oncol | 2022 |
| 32816252 | Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients: When to Stop? | Ann Surg Oncol | 2021 |
| 33736936 | Repeat Sentinel Lymph Node Surgery in Recurrent Breast Cancer: Peritumoral vs. Periareolar Injections. | Clin Breast Cancer | 2021 |
| 33839043 | Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology. | Clin Breast Cancer | 2021 |
| 33687613 | Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB). | Ann Surg Oncol | 2021 |
| 34651376 | Primary tumor resection in patients with stage IV breast cancer: 10-year experience. | Breast J | 2021 |
| 34275042 | Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy. | Ann Surg Oncol | 2021 |
| 34258721 | Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy. | Ann Surg Oncol | 2021 |
| 33462716 | Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy. | Ann Surg Oncol | 2021 |
| 32861439 | Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ. | Surgery | 2021 |
| 32649577 | Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer. | Pharmacogenet Genomics | 2021 |
| 32125938 | Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer. | J Clin Oncol | 2020 |
| 31758708 | Venous thromboembolism chemoprophylaxis in mastectomy patients: A 5-year follow-up study. | J Surg Oncol | 2020 |
| 31933142 | Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease. | Breast Cancer Res Treat | 2020 |